U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852469) titled 'Computational Assessment of GABA Receptor Modulation in PTSD' on Feb. 21.
Brief Summary: A substantial majority of Veterans with posttraumatic stress disorder (PTSD) continue to suffer even with the best current medications. Progress in developing more effective medications is hampered by the substantial variability within Veterans with PTSD, meaning the most effective medication likely varies from individual to individual. New scientific tools to help identify distinct subgroups of Veterans with PTSD who are likely to respond to specific medications could help improve treatment in this population. Research has indicated that a spec...